The Diagnostic Value of Onconeural Antibodies Depends on How They Are Tested

by Raquel Ruiz-García, Eugenia Martínez-Hernández, Eugenia Martínez-Hernández, Albert Saiz, Albert Saiz, Josep Dalmau, Josep Dalmau, Josep Dalmau, Francesc Graus
Published 2020-07-01

Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations

by Raquel Ruiz-García, Eugenia Martínez-Hernández, Eugenia Martínez-Hernández, Milagros García-Ormaechea, Marta Español-Rego, Lidia Sabater, Luis Querol, Luis Querol, Isabel Illa, Isabel Illa, Isabel Illa, Josep Dalmau, Josep Dalmau, Josep Dalmau, Francesc Graus
Published 2019-04-01

Limitations of a Commercial Assay as Diagnostic Test of Autoimmune Encephalitis

by Raquel Ruiz-García, Raquel Ruiz-García, Guillermo Muñoz-Sánchez, Laura Naranjo, Mar Guasp, Mar Guasp, Mar Guasp, Lidia Sabater, Albert Saiz, Albert Saiz, Josep Dalmau, Josep Dalmau, Josep Dalmau, Josep Dalmau, Josep Dalmau, Francesc Graus, Eugenia Martinez-Hernandez, Eugenia Martinez-Hernandez
Published 2021-06-01

Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity.

by Nuria Gresa-Arribas, Helena Ariño, Eugenia Martínez-Hernández, Mar Petit-Pedrol, Lidia Sabater, Albert Saiz, Josep Dalmau, Francesc Graus
Published 2015-01-01

Reduced serial dependence suggests deficits in synaptic potentiation in anti-NMDAR encephalitis and schizophrenia

by Heike Stein, Joao Barbosa, Mireia Rosa-Justicia, Laia Prades, Alba Morató, Adrià Galan-Gadea, Helena Ariño, Eugenia Martinez-Hernandez, Josefina Castro-Fornieles, Josep Dalmau, Albert Compte
Published 2020-08-01